These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2659241)

  • 41. CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests.
    Humphries RM; Ambler J; Mitchell SL; Castanheira M; Dingle T; Hindler JA; Koeth L; Sei K;
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29367292
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The present-day situation of standardization of antibiotic sensitivity testing in West Germany].
    Naumann P
    Infection; 1974; 2(1):52-5. PubMed ID: 4830533
    [No Abstract]   [Full Text] [Related]  

  • 43. The quality of antimicrobial susceptibility testing disks.
    Brown DF; Warner M; Bradley J; Taylor CE
    J Antimicrob Chemother; 1982 Nov; 10(5):373-82. PubMed ID: 7174564
    [No Abstract]   [Full Text] [Related]  

  • 44. A plea from EUCAST for standardization of disc susceptibility testing antimicrobial codes.
    Turnidge J; Lina G; Giske C;
    Clin Microbiol Infect; 2018 Dec; 24(12):1345. PubMed ID: 30107280
    [No Abstract]   [Full Text] [Related]  

  • 45. Impact of 21st Century Cures Act on Breakpoints and Commercial Antimicrobial Susceptibility Test Systems: Progress and Pitfalls.
    Humphries RM; Ferraro MJ; Hindler JA
    J Clin Microbiol; 2018 May; 56(5):. PubMed ID: 29436415
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative susceptibility test methods in major United States medical centers.
    Murray PR; Jorgensen JH
    Antimicrob Agents Chemother; 1981 Jul; 20(1):66-70. PubMed ID: 7283416
    [TBL] [Abstract][Full Text] [Related]  

  • 47. John C. Sherris, M.D.
    McAdam AJ
    J Clin Microbiol; 2012 Nov; 50(11):3416-7. PubMed ID: 22972815
    [No Abstract]   [Full Text] [Related]  

  • 48. The future of laboratory developed tests.
    Orton S
    MLO Med Lab Obs; 2012 Apr; 44(4):48. PubMed ID: 22586858
    [No Abstract]   [Full Text] [Related]  

  • 49. Towards a standardised method of susceptibility testing to improve sensitivity testing in the United Kingdom.
    Wise R
    J Antimicrob Chemother; 1995 Dec; 36(6):1103-4. PubMed ID: 8821613
    [No Abstract]   [Full Text] [Related]  

  • 50. Antibiotic susceptibility testing.
    Block C
    Methods Mol Med; 2001; 67():89-106. PubMed ID: 21337139
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selection criteria for an antimicrobial susceptibility testing system.
    Jorgensen JH
    J Clin Microbiol; 1993 Nov; 31(11):2841-4. PubMed ID: 8263164
    [No Abstract]   [Full Text] [Related]  

  • 52. Standardization of MIC testing.
    Wheldon DB; Slack MP
    J Antimicrob Chemother; 1978 Nov; 4(6):578-80. PubMed ID: 711655
    [No Abstract]   [Full Text] [Related]  

  • 53. A survey of antimicrobial susceptibility testing in the United Kingdom.
    Andrews JM; Brown D; Wise R
    J Antimicrob Chemother; 1996 Jan; 37(1):187-8. PubMed ID: 8647762
    [No Abstract]   [Full Text] [Related]  

  • 54. The international reference preparation of bleomycin.
    Lightbown JW; Gutteridge JM; Shute D
    J Biol Stand; 1981; 9(3):253-63. PubMed ID: 6168640
    [No Abstract]   [Full Text] [Related]  

  • 55. Letter: The disc sensitivity test.
    Ericsson H
    Br Med J; 1974 Sep; 3(5934):805-6. PubMed ID: 4414425
    [No Abstract]   [Full Text] [Related]  

  • 56. Survey of a laboratory building for airborne antibiotics.
    Garth MA; Bryant H; Kramer J; Kirshbaum A
    J Pharm Sci; 1971 Jan; 60(1):63-7. PubMed ID: 5107862
    [No Abstract]   [Full Text] [Related]  

  • 57. Regulating laboratory-developed tests.
    O'Leary TJ
    J Mol Diagn; 2014 Nov; 16(6):595-8. PubMed ID: 25307754
    [No Abstract]   [Full Text] [Related]  

  • 58. Antimicrobial susceptibility testing role of the clinical laboratory.
    Della-Latta P
    Diagn Microbiol Infect Dis; 1988 Mar; 9(3):133-4. PubMed ID: 3396301
    [No Abstract]   [Full Text] [Related]  

  • 59. In-vitro antimicrobial susceptibility testing: does it really matter?
    Finch RG
    J Chemother; 1997 May; 9 Suppl 1():3-6. PubMed ID: 9248956
    [No Abstract]   [Full Text] [Related]  

  • 60. A challenge accepted.
    Goddard JL
    J Am Pharm Assoc; 1966 Feb; 6(2):57 passim. PubMed ID: 5951824
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.